# AB Magnitude Ventures Group

> AB Magnitude Ventures Group is a VC fund backing Health Care and Biotechnology. See 5 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Total investments: 5
- Last investment: Jun 2025
- Lead investor: 20%
- Last updated: Aug 2026

AB Magnitude Ventures Group is an investment firm.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 3 | 60% |
| Biotechnology | 3 | 60% |
| Medical | 2 | 40% |
| Therapeutics | 2 | 40% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 2 | 40% |
| Seed | 1 | 20% |
| Series C | 1 | 20% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| ArrePath | ArrePath is an anti-infective drug discovery company addressing the global health challenge of drug resistant infections. |  | Seed | Jun 23, 2025 |  |
| Myrobalan Therapeutics | Myro Therapeutics is a biotechnology company that focuses on the development of therapeutic solutions for Central Nervous System (CNS) disorders. The company's approach is rooted in a deep understanding of disease biology and mechanisms, which allows for the selection of targets that can effectively combat these disorders. Myro Therapeuticshas a dedicated team of scientists who work tirelessly to advance the company's research and development efforts. The company has recently celebrated its second anniversary and has also moved into a new office space, indicating a period of growth and expansion. | $24M | Series A | Jan 10, 2024 |  |
| Odyssey Therapeutics | Odyssey Therapeutics is a biotechnology company pioneering the efficient development of next-generation immunomodulators and oncology medicines. Odyssey is making a transformational impact on the field of drug discovery and is accelerating the path to clinical development to drive the creation of more effective precision medicines. | $101M | Series C | Dec 05, 2023 |  |
| Oloren AI | Oloren AI offers a molecular descriptor that leverages information from millions of publically curated datasets. The company was founded in 2021 and is headquartered in San Diego, California, United States. | $300K | Pre-Seed | Aug 31, 2022 |  |
| BAKX Therapeutics | BAKX Therapeutics is a provider of cancer treatment. | $25M | Series A | Nov 18, 2021 |  |

5 of 5 investments shown.

## Co-investors
- [3E Bioventures](https://shizune.co/investors/profile/3e-bioventures) — VC Fund, 1 deal together
- [Alexandria Venture Investments](https://shizune.co/investors/profile/alexandria-venture-investments) — VC Fund, 1 deal together
- Ascenta Capital — VC Fund, 1 deal together
- [BlackMars Capital](https://shizune.co/investors/profile/blackmars-capital) — VC Fund, 1 deal together
- [Boehringer Ingelheim Venture Fund](https://shizune.co/investors/profile/boehringer-ingelheim-venture-fund) — VC Fund, 1 deal together
- [Catalio Capital Management](https://shizune.co/investors/profile/catalio-capital-management) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does AB Magnitude Ventures Group invest in?

AB Magnitude Ventures Group invests primarily in Health Care, Biotechnology and Medical startups, most often at Series A and Seed stage. Most of the 5 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did AB Magnitude Ventures Group last invest?

The most recent investment recorded for AB Magnitude Ventures Group closed in Jun 2025. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co